SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-054149
Filing Date
2024-04-29
Accepted
2024-04-29 17:02:08
Documents
8
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2410169-1_def14a.htm DEF 14A 682231
2 GRAPHIC bc_investment-4clr.jpg GRAPHIC 56378
3 GRAPHIC bc_investmenttsr-4clr.jpg GRAPHIC 60402
4 GRAPHIC bc_netincome-4clr.jpg GRAPHIC 58271
5 GRAPHIC bc_netloss-4clr.jpg GRAPHIC 53757
6 GRAPHIC px_armataproxy1pg1-bw.jpg GRAPHIC 250974
7 GRAPHIC px_armataproxy1pg2-bw.jpg GRAPHIC 240539
8 GRAPHIC sg_robinckramer-bw.jpg GRAPHIC 8233
  Complete submission text file 0001104659-24-054149.txt   1621476
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37544 | Film No.: 24892342
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)